( 607) 227-8695 info@prendismo.com

Bryan Pearce Discusses Changes in VC Firm Activity From 2000 To 2005

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 6/2/2005
  • Clip Duration : 2 min. 23 sec.

Playlists

Please Login to create playlists

Bryan Pearce

  • Partner, Ernst & Young
  • male
  • Caucasian
  • 1963 (Age: 58 years old)
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • Video 1 of 20 in this Case
  • View All Available Videos

Biography

Bryan Pearce is a partner in the technology and life sciences practice of the firm, based in Boston MA, where he leads the firm's New England Venture Capital Advisory Group ("VCAG"). VCAG focuses on development and delivery of value added services to the venture capital industry, including core audit and tax services as well as deal flow, knowledge and thought leadership, and access to our alumni and extended enterprise networks and perspective on current venture capital fundraising trends. In addition, Bryan spends a substantial portion of his time with Emerging Growth companies providing counsel in the areas of fundraising, business models, preparing for a liquidity event, etc. He also is a member of the Global Steering Committee for this important component of the Global E&Y strategy.

Bryan began his career with the firm in 1981 after graduating from the Ivey School of Business at the University of Western Ontario (Canada) and obtained his Canadian Chartered Accountant designation in 1983. Between 1995 and 2000 Bryan was seconded to the Caribbean practice, based in Barbados, where he was responsible for developing and running the Caribbean firm's Corporate Finance and Entrepreneurial Services' practice.

The other thing that has happened is the number of VC firms has really changed dramatically since the bubble. This is 2000 on the far left. You can see we have 1,231 active venture capital firms in the country. And by our definition, it is fairly easy to be active. It's basically you did a deal a qu...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

Bryan Pearce videos

Video 1 of 20 Phil Weilerstein Provides Welcome and Overview to NCIIA Meeting
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 2 min. 33 sec.
Video 2 of 20 Bryan Pearce Provides Introduction To Talk and Shares Thoughts on Why Academics Are Linked To Biotech Companies
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 1 min. 49 sec.
Video 3 of 20 Bryan Pearce States Universities Must Be Catalysts For Technology Transfer
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 0 min. 48 sec.
Video 4 of 20 Bryan Pearce Shares Thoughts on the Technology Transfer Process
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 1 min. 48 sec.
Video 5 of 20 Steve Buckley Provides Overview of Biotechnology Industry in mid-2005
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 5 min. 4 sec.
Video 6 of 20 Bryan Pearce Investigates Influence of Venture Capital on Biotech Industry in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 1 min. 38 sec.
Video 7 of 20 Bryan Pearce Investigates VC Investment in the Healthcare Sector
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 14 sec.
Video 8 of 20 Bryan Pearce Discusses IPO Exit Strategies Among Healthcare-Related Companies in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 29 sec.
Video 9 of 20 Bryan Pearce Discusses Profit From VC Investment in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 20 sec.
Video 10 of 20 Bryan Pearce Discusses Profit From VC Investment in Healthcare Ventures in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 5 sec.
Video 11 of 20 Bryan Pearce States Pace of Company Closure Has Slowed in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 0 min. 45 sec.
Video 12 of 20 Bryan Pearce Discusses Follow-On Financing in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 43 sec.
Video 13 of 20 Bryan Pearce Discusses Changes in VC Firm Activity From 2000 To 2005
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 23 sec.
Video 14 of 20 Bryan Pearce States Reality Is That Biotech Startups Face a Rough Road In Terms of Financing
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 1 min. 17 sec.
Video 15 of 20 Steve Buckley Discusses General Market Performance From 2000 To 2005
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 2 min. 52 sec.
Video 16 of 20 Steve Buckley Shares Thoughts on Partner Alliances In Biotech Industry
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 3 min. 19 sec.
Video 17 of 20 Steve Buckley Discusses Transaction Value And Trends in Drug Approval Process
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 5 min. 8 sec.
Video 18 of 20 Steve Buckley Shares Thoughts on Future Forecast Within Biotech Industry
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 3 min. 58 sec.
Video 19 of 20 Bryan Pearce Shares Thoughts on Early Stage Funding Gap For Biotechnology Startups
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 28 sec.
Video 20 of 20 Steve Buckley Shares Thoughts Bubble and Future of VC Investing Internationally
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 1 min. 50 sec.

RELATED VIDEOS

Phil Weilerstein Provides Welcome and Overview to NCIIA Meeting
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 2 min. 33 sec.
Bryan Pearce Provides Introduction To Talk and Shares Thoughts on Why Academics Are Linked To Biotech Companies
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 1 min. 49 sec.
Bryan Pearce States Universities Must Be Catalysts For Technology Transfer
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 0 min. 48 sec.
Bryan Pearce Shares Thoughts on the Technology Transfer Process
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 1 min. 48 sec.
Steve Buckley Provides Overview of Biotechnology Industry in mid-2005
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Steve Buckley
  • 5 min. 4 sec.
Bryan Pearce Investigates Influence of Venture Capital on Biotech Industry in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 1 min. 38 sec.
Bryan Pearce Investigates VC Investment in the Healthcare Sector
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 14 sec.
Bryan Pearce Discusses Profit From VC Investment in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 20 sec.
Bryan Pearce Discusses Profit From VC Investment in Healthcare Ventures in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 2 min. 5 sec.
Bryan Pearce States Pace of Company Closure Has Slowed in 2004
  • Invention to Venture - June 2005 - Session 1 - Ernst & Young Life Science Report
  • 6/2/2005
  • Bryan Pearce
  • 0 min. 45 sec.